Compare COO & TOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COO | TOL |
|---|---|---|
| Founded | 1980 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5B | 13.8B |
| IPO Year | N/A | N/A |
| Metric | COO | TOL |
|---|---|---|
| Price | $81.98 | $139.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 15 |
| Target Price | $85.82 | ★ $151.60 |
| AVG Volume (30 Days) | ★ 3.3M | 989.3K |
| Earning Date | 12-04-2025 | 12-08-2025 |
| Dividend Yield | N/A | ★ 0.72% |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.87 | ★ 13.61 |
| Revenue | $4,092,400,000.00 | ★ $10,876,787,000.00 |
| Revenue This Year | $6.66 | $0.45 |
| Revenue Next Year | $5.54 | N/A |
| P/E Ratio | $43.53 | ★ $10.21 |
| Revenue Growth | ★ 5.06 | 3.26 |
| 52 Week Low | $61.78 | $86.67 |
| 52 Week High | $104.47 | $157.79 |
| Indicator | COO | TOL |
|---|---|---|
| Relative Strength Index (RSI) | 72.89 | 56.50 |
| Support Level | $75.25 | $136.76 |
| Resistance Level | $78.69 | $145.01 |
| Average True Range (ATR) | 2.48 | 3.75 |
| MACD | 0.47 | 1.05 |
| Stochastic Oscillator | 55.39 | 71.48 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Toll Brothers is the leading luxury homebuilder in the United States with an average sale price well above public competitors'. The company operates in over 60 markets across 24 states and caters to move-up, active-adult, and second-homebuyers. Traditional homebuilding operations represent most of company's revenue. Toll Brothers also builds luxury for-sale and for-rent properties in urban centers across the US. It has its headquarters in Horsham, Pennsylvania.